Cargando…
Dexamethasone Sustained-Release Intracanalicular Insert for Control of Postoperative Inflammation After Pars Plana Vitrectomy
PURPOSE: To evaluate the safety and efficacy of a dexamethasone sustained-release intracanalicular insert (DII) (Dextenza(®) Ocular Therapeutix, Inc., Bedford, MA) for control of inflammation and pain after pars plana vitrectomy (PPV) compared to standard topical steroid therapy. METHODS: Retrospect...
Autores principales: | Suñer, Ivan J, Peden, Marc C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455509/ https://www.ncbi.nlm.nih.gov/pubmed/34556974 http://dx.doi.org/10.2147/OPTH.S330255 |
Ejemplares similares
-
Pars plana Baerveldt tube insertion with pars plana vitrectomy for refractory glaucoma
por: Kolomeyer, Anton M., et al.
Publicado: (2012) -
Retrospective Study of a Sustained-Release Intracanalicular Dexamethasone Insert for Treatment of Ocular Inflammation After Cataract and Corneal Surgery
por: Fram, Nicole, et al.
Publicado: (2022) -
Inflammation and Macular Oedema after Pars Plana Vitrectomy
por: Romano, Vito, et al.
Publicado: (2013) -
Postoperative rhabdomyolysis following pars-plana vitrectomy under general anesthesia
por: Campbell, John P, et al.
Publicado: (2013) -
Early Real-World Physician Experience with an Intracanalicular Dexamethasone Insert
por: Matossian, Cynthia, et al.
Publicado: (2022)